TANG CAPITAL MANAGEMENT LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001232621

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFocusedHealth Tilt how tags are computed

Q3 2026 · 45 positions · Total reported value $2.17B · Top-10 concentration 64.3% · Updated 2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

Turnover: 15.2% · 5 new · 1 cut · 1 exited

Active Share (vs S&P 500): 99.9% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -8.5% · vs SPY -10.6% · Prev Value $2.20B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -3.0% · vs SPY -5.2% · Latest Value $2.17B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2026 13F filing, TANG CAPITAL MANAGEMENT LLC disclosed 45 equity positions with a combined reported value of $2.17B. The filing implies a focused portfolio: its ten largest positions account for 64.3% of reported value. HoldingsHub classifies the profile as Mid / Focused / Health Tilt.

The largest disclosed positions as of Q3 2026 were AUPH ($211.25M), CORT ($172.84M), KNSA ($168.61M). By sector, the heaviest allocations are Health Care 89.7%, Information Technology 1.5%. Versus the prior quarter, allocation shifted toward Information Technology (+0.6pp) and away from Other (-0.6pp).

Versus the prior quarter, TANG CAPITAL MANAGEMENT LLC opened 5 new positions, trimmed 1 and fully exited 1, a turnover rate of 15.2% of positions. The portfolio's overlap with the prior quarter was 87% of names.

The largest new positions opened in Q3 2026 were ARDX ($30.94M), VERA ($16.14M), LEGN ($13.92M).

Of the 1 positions fully exited versus the prior quarter, the largest were CAPR ($98.73M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2026)

  • ARDX ARDELYX INC · $30.94M
  • VERA VERA THERAPEUTICS INC · $16.14M
  • LEGN LEGEND BIOTECH CORP · $13.92M
  • SION SIONNA THERAPEUTICS INC · $657.50K
  • SKYE SKYE BIOSCIENCE INC · $322.00K

Fully Exited (vs previous quarter)

  • CAPR CAPRICOR THERAPEUTICS INC · prev qtr: $98.73M

Insider Transactions (Form 4)

Latest TANG CAPITAL MANAGEMENT LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-11-10 Buy Boundless Bio, Inc. 249 $2.40 SEC filing
2026-11-06 Buy Boundless Bio, Inc. 1,700 $2.40 SEC filing
2026-11-05 Buy Boundless Bio, Inc. 8,390 $2.40 SEC filing
2026-11-04 Buy Boundless Bio, Inc. 517 $2.40 SEC filing
2026-11-03 Buy Boundless Bio, Inc. 2,255 $2.40 SEC filing
2026-10-27 Buy Boundless Bio, Inc. 10,707 $2.40 SEC filing
2026-10-26 Buy Boundless Bio, Inc. 9,606 $2.38 SEC filing
2026-10-23 Buy Boundless Bio, Inc. 6,234 $2.38 SEC filing

All insider transactions →

Fund Profile

Tang Capital Management is an SEC-registered 13F filer. As of Q3 2026 it reported 45 US equity positions with a combined value of $2.17B. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Portfolio Structure

  • 45 positions · $2.17B reported value (Q3 2026)
  • Top 10 holdings = 64.3% of reported value
  • Largest position: AUPH (AURINIA PHARMACEUTICALS INC) at 9.7%
  • Average position size: $48.31M

Sector Tilt

  • Health Care 89.7%
  • Information Technology 1.5%
  • (classified holdings cover 91% of value)

Quarterly Activity

  • Q3 2026: 5 new, 12 added, 1 reduced, 1 exited
  • 27 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall direction and market view: The fund increased exposure to select biotech/healthcare names (TARS, LKFT, CELC, IMCR) while trimming others (MIRM, PTCT), suggesting a tactical tilt toward undervalued or high-potential therapeutics amid sector volatility. 2. Key moves: - Added: TARS (+22.3% shares, wt↑1.45ppt), LKFT (+5.3% shares, wt↑0.28ppt), CELC (+11.4% shares, wt↓0.89ppt but action=Add), IMCR (+8.9% shares, wt↑0.20ppt). - Reduced: MIRM (wt↓1.71ppt), PTCT (wt↓1.09ppt); no explicit "Reduce" actions per data. 3. Portfolio structure: Active, concentrated (45 positions), heavily biased toward Health Care (biopharma/therapeutics), with moderate risk appetite (high-conviction bets, no ETFs). 4. Per-holding one-liner: - AUPH: Autoimmune drug developer (Aurinia). - CORT: Corticosteroid therapies (Corcept). - KNSA: Inflammatory/immune disease drugs (Kiniksa). - SYRE: Dermatology-focused biotech (Spyre). - TARS: Anti-infectives developer (Tarsus). - LKFT: Cell therapy biotech (Lakefront). - CELC: Cancer drug platform (Celcuity). - MIRM: Liver disease treatments (Mirum). - PTCT: Rare disease drugs (PTC Therapeutics). - IMCR: T-cell therapies (Immunocore). 5. Style summary: Biotech-focused active manager tactically reallocating capital to high-growth therapeutic candidates while trimming laggards.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice. · AI generated 2026-11-17 10:11

Sector Allocation

Health Care 89.7%
Other 8.8%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 13.04M $211.25M 9.72%
9.72%
Hold
2 1.50M $172.84M 7.95%
7.95%
Hold
3 2.26M $168.61M 7.76%
7.76%
Hold
4 1.89M $168.46M 7.75%
7.75%
Hold
5 1.92M $150.75M 6.93%
6.93%
Add
6 3.99M $118.18M 5.44%
5.44%
Add
7 1.46M $116.46M 5.36%
5.36%
Add
8 1.24M $105.66M 4.86%
4.86%
Hold
9 1.50M $97.17M 4.47%
4.47%
Hold
10 2.88M $87.36M 4.02%
4.02%
Add
11 1.47M $74.10M 3.41%
3.41%
Add
12 95.00K $72.45M 3.33%
3.33%
Reduce
13 5.20M $64.69M 2.98%
2.98%
Add
14 6.42M $54.93M 2.53%
2.53%
Hold
15 707.50K $51.40M 2.37%
2.37%
Hold
16 470.00K $46.20M 2.12%
2.12%
Hold
17 1.79M $36.91M 1.70%
1.70%
Hold
18 1.58M $33.33M 1.53%
1.53%
Add
19 20.93M $32.86M 1.51%
1.51%
Add
20 9.05M $30.94M 1.42%
1.42%
New
21 7.08M $26.20M 1.21%
1.21%
Add
22 4.81M $25.08M 1.15%
1.15%
Hold
23 264.69K $23.31M 1.07%
1.07%
Hold
24 17.99M $18.71M 0.86%
0.86%
Hold
25 3.30M $18.48M 0.85%
0.85%
Hold
26 450.00K $17.29M 0.80%
0.80%
Hold
27 1.16M $16.92M 0.78%
0.78%
Hold
28 500.00K $16.30M 0.75%
0.75%
Hold
29 500.00K $16.14M 0.74%
0.74%
New
30 700.00K $13.92M 0.64%
0.64%
New
31 7.29M $12.17M 0.56%
0.56%
Add
32 100.00K $11.41M 0.53%
0.53%
Hold
33 17.84M $11.16M 0.51%
0.51%
Hold
34 1.61M $11.01M 0.51%
0.51%
Hold
35 50.00K $9.63M 0.44%
0.44%
Hold
36 300.00K $7.80M 0.36%
0.36%
Hold
37 2.84M $7.13M 0.33%
Form 4 · 13 →
0.33%
Add
38 6.14M $6.63M 0.30%
0.30%
Hold
39 8.97M $2.81M 0.13%
0.13%
Add
40 600.00K $2.22M 0.10%
0.10%
Hold
41 666.02K $1.90M 0.09%
0.09%
Hold
42 451.11K $1.73M 0.08%
0.08%
Hold
43 125.00K $657.50K 0.03%
0.03%
New
44 200.00K $322.00K 0.01%
0.01%
New
45 100.00K $263.00K 0.01%
0.01%
Hold

FAQ

What did TANG CAPITAL MANAGEMENT LLC buy in 2026-Q3?

In its 2026-Q3 13F filing, TANG CAPITAL MANAGEMENT LLC reported 45 equity positions worth $2.17B in aggregate; its largest disclosed positions were AUPH ($211.25M), CORT ($172.84M), KNSA ($168.61M).

How large is TANG CAPITAL MANAGEMENT LLC's portfolio?

TANG CAPITAL MANAGEMENT LLC reported $2.17B of long equity holdings across 45 positions as of 2026-Q3. Top-10 holdings account for 64.3% of reported value.

What is TANG CAPITAL MANAGEMENT LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Focused / Health Tilt, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/tang-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →